STOCK TITAN

Intevac Announces Second Quarter 2021 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Intevac reported financial results for Q2 2021, with revenues of $13.8 million, below $28.8 million from Q2 2020. The company faced a net loss of $6.1 million, translating to a loss of $0.25 per share. Key drivers included technology upgrades by HDD customers, revealing a $15 million backlog increase in the Thin-film Equipment (TFE) sector. Photonics revenue decreased to $8.4 million due to integration costs with the IVAS platform. Despite challenges, Intevac maintains a strong financial position with $54.1 million in cash and a backlog of $51.7 million.

Positive
  • $15 million increase in TFE backlog.
  • Continued investment from the U.S. Military in Intevac's Photonics.
  • Strong cash position of $54.1 million.
Negative
  • Net loss of $6.1 million for Q2 2021.
  • Revenues declined from $28.8 million in Q2 2020 to $13.8 million in Q2 2021.
  • TFE gross margin dropped to 18.7% from 36.4% in Q2 2020.

Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the quarter and six months ended July 3, 2021.

“We are pleased to report revenues above forecast for the second quarter, chiefly as a result of the acceleration of technology upgrades by our hard disk drive (HDD) customers,” commented Wendell Blonigan, president and chief executive officer. “We announced a record HDD upgrade order in June, which also drove the majority of the $15 million increase in backlog in our Thin-film Equipment (TFE) business in the quarter. In our Photonics business, we announced two new development program awards in June, both of which are aimed at improving the low light level night vision performance of the current IVAS headset.

“In addition to these announcements, we are pleased to report positive developments on multiple other fronts during the second quarter. First, with recent HDD industry reports indicating continued upside in mass-capacity drives and overall HDD units, as well as in total media units and exabytes shipped, the discussions with our customers to add media capacity have resumed. Furthermore, we continued to attain progress with our INTEVAC VERTEX® protective coating programs, which increases our confidence in new orders as well as for our overall VERTEX growth initiative. Lastly, the U.S. Military continues to invest in Intevac Photonics as a key night vision technology provider for all of its digital programs, including IVAS.” Mr. Blonigan concluded, “While 2021 is a challenging year, we continue to maintain solid financial footing, with a strong balance sheet, increasing orders and backlog, and continued momentum on a number of programs and growth initiatives that put Intevac firmly on a path for growth in 2022 and beyond.”

($ Millions, except per share amounts)

 

 

 

 

Three Months Ended

 

Three Months Ended

 

 

July 3, 2021

 

June 27, 2020

 

 

GAAP Results

 

Non-GAAP
Results

 

GAAP Results

 

Non-GAAP
Results

Net Revenues

 

$

13.8

 

 

$

13.8

 

 

$

28.8

 

$

28.8

Operating Income (Loss)

 

$

(6.3

)

 

$

(6.3

)

 

$

2.1

 

$

2.1

Net Income (Loss)

 

$

(6.1

)

 

$

(6.1

)

 

$

1.5

 

$

1.5

Net Income (Loss) per Share

 

$

(0.25

)

 

$

(0.25

)

 

$

0.06

 

$

0.06

 

 

 

Six Months Ended

 

Six Months Ended

 

 

July 3, 2021

 

June 27, 2020

 

 

GAAP Results

 

Non-GAAP
Results

 

GAAP Results

 

Non-GAAP
Results

Net Revenues

 

$

30.1

 

 

$

30.1

 

 

$

47.7

 

$

47.7

Operating Income (Loss)

 

$

(12.8

)

 

$

(12.8

)

 

$

1.0

 

$

1.0

Net Income (Loss)

 

$

(12.6

)

 

$

(12.6

)

 

$

0.3

 

$

0.3

Net Income (Loss) per Share

 

$

(0.52

)

 

$

(0.52

)

 

$

0.01

 

$

0.01

Intevac’s non-GAAP adjusted results exclude the impact, where applicable, of restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.

Second Quarter 2021 Summary

The net loss for the quarter was $6.1 million, or $0.25 per diluted share, compared to net income of $1.5 million, or $0.06 per diluted share, in the second quarter of 2020.

Revenues were $13.8 million, including $5.4 million of TFE revenues and $8.4 million of Photonics revenues. TFE revenues consisted of upgrades, spares and service. Photonics revenues consisted of $3.2 million of research and development contracts and $5.3 million of product sales. In the second quarter of 2020, revenues were $28.8 million, including $16.6 million of TFE revenues, which consisted of two 200 Lean HDD systems, upgrades, spares and service, and Photonics revenues of $12.2 million, which included $6.1 million of research and development contracts and $6.1 million of product sales.

TFE gross margin was 18.7% compared to 36.4% in the second quarter of 2020 and 23.1% in the first quarter of 2021. The decline from the first quarter of 2021 and the second quarter of 2020 was primarily due to lower revenues which affected factory utilization.

Photonics gross margin was 24.9% compared to 43.9% in the second quarter of 2020 and 13.1% in the first quarter of 2021. The decline from the second quarter of 2020 was primarily due to lower revenue levels, as well as higher costs related to completing the integration of our camera into the IVAS platform. The improvement from the first quarter of 2021 was primarily due to a sequential increase in revenues and higher margins on development programs. Consolidated gross margin was 22.5%, compared to 39.6% in the second quarter of 2020 and 18.8% in the first quarter of 2021.

R&D and SG&A expenses were $9.4 million, compared to $9.3 million in the second quarter of 2020 and $9.6 million in the first quarter of 2021.

Order backlog totaled $51.7 million on July 3, 2021, compared to $43.1 million on April 3, 2021 and $69.0 million on June 27, 2020. Backlog at July 3, 2021, April 3, 2021 and June 27, 2020 did not include any 200 Lean HDD systems.

The Company ended the quarter with $54.1 million of total cash, cash equivalents, restricted cash and investments and $91.7 million in tangible book value.

First Six Months 2021 Summary

The net loss was $12.6 million, or $0.52 per diluted share, compared to net income of $0.3 million, or $0.01 per diluted share, for the first six months of 2020.

Revenues were $30.1 million, including $14.6 million of TFE revenues and $15.4 million of Photonics revenues, compared to first-half 2020 revenues of $47.7 million, which included $24.6 million of TFE revenues and $23.1 million of Photonics revenues.

TFE gross margin declined to 21.5%, compared to 38.9% in the first six months of 2020, primarily due to lower revenues and less favorable product mix. Photonics gross margin declined to 19.6%, compared to 43.4% in the first six months of 2020, primarily due to higher costs related to completing the integration of our camera into the IVAS platform, as well as lower product margins. Consolidated gross margin was 20.5%, compared to 41.1% in the first six months of 2020.

R&D and SG&A expenses were $19.0 million compared to $18.6 million in the first six months of 2020.

Use of Non-GAAP Financial Measures

Intevac's non-GAAP results exclude the impact, where applicable, of restructuring charges. A reconciliation of the GAAP and non-GAAP results is provided in the financial tables included in this release.

Management uses non-GAAP results to evaluate the Company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. Intevac believes these measures enhance investors’ ability to review the Company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP.

Conference Call Information

The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the teleconference, please call toll-free (877) 407-0989 prior to the start time, and reference meeting number 13721096. For international callers, the dial-in number is +1 (201) 389-0921. You may also listen live via the Internet on the Company's investor relations website at https://ir.intevac.com. For those unable to attend live, an archived webcast of the call will be available at https://ir.intevac.com.

About Intevac

Intevac was founded in 1991 and has two businesses: Thin-film Equipment and Photonics.

In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, solar photovoltaic, and advanced semiconductor packaging markets we serve currently.

In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most U.S. military night vision programs.

For more information call 408-986-9888, or visit the Company's website at www.intevac.com.

200 Lean®, INTEVAC MATRIX®, INTEVAC VERTEX®, ENERGi®, LIVAR®, DiamondClad®, VERTEX Marathon®, and VERTEX Spectra® are registered trademarks of Intevac, Inc.

Safe Harbor Statement

This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Intevac claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” or “anticipates,” and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: impacts related to the COVID-19 global pandemic, customer adoption of our products, future revenue growth potential, and the future financial performance of Intevac. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the Company’s expectations. These risks include, but are not limited to: global economic impacts of COVID-19 including delays in customer evaluations, supply chain constraints and disruptions related to COVID-19, technology risk, challenges achieving customer adoption and revenue growth in Thin-film Equipment markets, and delays in Photonics programs, each of which could have a material impact on our business, our financial results, and the Company's stock price. These risks and other factors are detailed in the Company’s periodic filings with the U.S. Securities and Exchange Commission.

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except per share amounts)

 

 

 

Three months ended

 

Six months ended

 

 

July 3,
2021

 

June 27,
2020

 

July 3,
2021

 

June 27,
2020

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

TFE

 

$

5,369

 

 

$

16,595

 

 

$

14,607

 

 

$

24,557

 

Photonics

 

 

8,444

 

 

 

12,247

 

 

 

15,447

 

 

 

23,125

 

Total net revenues

 

 

13,813

 

 

 

28,842

 

 

 

30,054

 

 

 

47,682

 

Gross profit

 

 

3,108

 

 

 

11,420

 

 

 

6,162

 

 

 

19,577

 

Gross margin

 

 

 

 

 

 

 

 

 

 

 

 

TFE

 

 

18.7

%

 

 

36.4

%

 

 

21.5

%

 

 

38.9

%

Photonics

 

 

24.9

%

 

 

43.9

%

 

 

19.6

%

 

 

43.4

%

Consolidated

 

 

22.5

%

 

 

39.6

%

 

 

20.5

%

 

 

41.1

%

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

3,894

 

 

 

3,707

 

 

 

7,519

 

 

 

6,991

 

Selling, general and administrative

 

 

5,525

 

 

 

5,609

 

 

 

11,455

 

 

 

11,581

 

Total operating expenses

 

 

9,419

 

 

 

9,316

 

 

 

18,974

 

 

 

18,572

 

Total operating income (loss)

 

 

(6,311

)

 

 

2,104

 

 

 

(12,812

)

 

 

1,005

 

Income (loss) from operations

 

 

 

 

 

 

 

 

 

 

 

 

TFE

 

 

(4,305

)

 

 

(174

)

 

 

(8,306

)

 

 

(2,705

)

Photonics

 

 

(255

)

 

 

3,536

 

 

 

(1,401

)

 

 

6,448

 

Corporate

 

 

(1,751

)

 

 

(1,258

)

 

 

(3,105

)

 

 

(2,738

)

Total operating income (loss)

 

 

(6,311

)

 

 

2,104

 

 

 

(12,812

)

 

 

1,005

 

Interest and other income (expense), net

 

 

20

 

 

 

62

 

 

 

50

 

 

 

204

 

Income (loss) before provision for (benefit from) income taxes

 

 

(6,291

)

 

 

2,166

 

 

 

(12,762

)

 

 

1,209

 

Provision for (benefit from) income taxes

 

 

(165

)

 

 

642

 

 

 

(132

)

 

 

909

 

Net income (loss)

 

$

(6,126

)

 

$

1,524

 

 

$

(12,630

)

 

$

300

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.25

)

 

$

0.06

 

 

$

(0.52

)

 

$

0.01

 

Diluted

 

$

(0.25

)

 

$

0.06

 

 

$

(0.52

)

 

$

0.01

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,241

 

 

 

23,561

 

 

 

24,137

 

 

 

23,522

 

Diluted

 

 

24,241

 

 

 

23,906

 

 

 

24,137

 

 

 

23,953

 

INTEVAC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)

 

 

 

July 3,
2021

 

January 2,
2021

 

 

(Unaudited)

 

(see Note)

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash, cash equivalents and short-term investments

 

$

48,661

 

 

$

44,180

 

Accounts receivable, net

 

 

14,356

 

 

 

28,646

 

Inventories

 

 

20,524

 

 

 

21,689

 

Prepaid expenses and other current assets

 

 

1,691

 

 

 

1,893

 

Total current assets

 

 

85,232

 

 

 

96,408

 

Long-term investments

 

 

4,679

 

 

 

5,388

 

Restricted cash

 

 

787

 

 

 

787

 

Property, plant and equipment, net

 

 

9,683

 

 

 

11,004

 

Operating lease right-of-use-assets

 

 

6,988

 

 

 

8,165

 

Deferred income tax and other long-term assets

 

 

5,700

 

 

 

5,486

 

Total assets

 

$

113,069

 

 

$

127,238

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Current operating lease liabilities

 

$

2,981

 

 

$

2,853

 

Accounts payable

 

 

3,890

 

 

 

4,259

 

Accrued payroll and related liabilities

 

 

6,334

 

 

 

7,679

 

Other accrued liabilities

 

 

2,421

 

 

 

3,631

 

Total current liabilities

 

 

15,626

 

 

 

18,422

 

Non-current liabilities

 

 

 

 

 

 

Non-current operating lease liabilities

 

 

5,267

 

 

 

6,803

 

Other long-term liabilities

 

 

428

 

 

 

457

 

Total non-current liabilities

 

 

5,695

 

 

 

7,260

 

Stockholders’ equity

 

 

 

 

 

 

Common stock ($0.001 par value)

 

 

24

 

 

 

24

 

Additional paid-in capital

 

 

196,064

 

 

 

193,173

 

Treasury stock, at cost

 

 

(29,551

)

 

 

(29,551

)

Accumulated other comprehensive income

 

 

571

 

 

 

640

 

Accumulated deficit

 

 

(75,360

)

 

 

(62,730

)

Total stockholders’ equity

 

 

91,748

 

 

 

101,556

 

Total liabilities and stockholders’ equity

 

$

113,069

 

 

$

127,238

 

Note: Amounts as of January 2, 2021 are derived from the January 2, 2021 audited consolidated financial statements.

INTEVAC, INC.

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(Unaudited, in thousands, except per share amounts)

 

 

 

Three months ended

 

Six months ended

 

 

July 3,
2021

 

June 27,
2020

 

July 3,
2021

 

June 27,
2020

Non-GAAP Income (Loss) from Operations

 

 

 

 

 

 

 

 

 

 

 

 

Reported operating income (loss) (GAAP basis)

 

$

(6,311

)

 

$

2,104

 

$

(12,812

)

 

$

1,005

Restructuring charges 1

 

 

 

 

 

 

 

43

 

 

 

Non-GAAP Operating Income (Loss)

 

$

(6,311

)

 

$

2,104

 

$

(12,769

)

 

$

1,005

Non-GAAP Net Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

Reported net income (loss) (GAAP basis)

 

$

(6,126

)

 

$

1,524

 

$

(12,630

)

 

$

300

Restructuring charges 1

 

 

 

 

 

 

 

43

 

 

 

Non-GAAP Net Income (Loss)

 

$

(6,126

)

 

$

1,524

 

$

(12,587

)

 

$

300

Non-GAAP Net Income (Loss) Per Diluted Share

 

 

 

 

 

 

 

 

 

 

 

 

Reported net income (loss) per diluted share (GAAP basis)

 

$

(0.25

)

 

$

0.06

 

$

(0.52

)

 

$

0.01

Restructuring charges 1

 

$

 

 

$

 

$

 

 

$

Non-GAAP Net Income (Loss) Per Diluted Share

 

$

(0.25

)

 

$

0.06

 

$

(0.52

)

 

$

0.01

Weighted average number of diluted shares

 

 

24,241

 

 

 

23,906

 

 

24,137

 

 

 

23,953

1Results for the six months ended July 3, 2021 include severance and other employee-related costs related to a restructuring program.

 

FAQ

What were Intevac's Q2 2021 revenues?

Intevac reported revenues of $13.8 million for Q2 2021.

How did Intevac perform compared to Q2 2020?

Intevac's revenues declined from $28.8 million in Q2 2020 to $13.8 million in Q2 2021.

What was Intevac's net loss for Q2 2021?

The net loss for Q2 2021 was $6.1 million, or $0.25 per diluted share.

What is Intevac's order backlog as of July 3, 2021?

Intevac's order backlog totaled $51.7 million on July 3, 2021.

What are the main drivers behind Intevac's growth in Q2 2021?

Growth was driven by HDD technology upgrades and military investments in Photonics.

Intevac Inc

NASDAQ:IVAC

IVAC Rankings

IVAC Latest News

IVAC Stock Data

89.85M
26.94M
4.05%
70.29%
0.47%
Specialty Industrial Machinery
Special Industry Machinery, Nec
Link
United States of America
SANTA CLARA